VækstPartner Kapital and founders and management sell CIM Industrial Systems to XANO
VækstPartner Kapital and the founders and management of the leading pharma/industry 4.0 production software specialist CIM Industrial Systems A/S have sold the company to the listed Swedish group XANO Industri AB.
CIM is a leading production software specialist. Based on its own software products and frameworks, CIM provides end-to-end production software solutions within industrial IoT, track & trace/serialization, machine vision and test & measurement, as well as related custom work. CIM’s solutions enable their customers to make business-critical decisions based on reliable data. Customers include blue-chip pharmaceutical and infrastructure companies. CIM has approximately 50 employees. Sales totaled US$9.3 million in 2020. The company is in an expanding phase and expects a growth of around 15% in 2021, related to both existing and new market segments.
XANO develops, acquires and operates niche engineering companies offering manufacturing and development services for industrial products and automation equipment. The group’s operations are divided into three business units and are represented in the Nordic countries, Estonia, the Netherlands, Poland, China and the US. Consolidated revenue totals over US$326 million and the number of employees is approximately 1,200. XANO has been listed on the Stockholm Stock Exchange since 1988.
Oaklins’ team in Denmark acted as the exclusive sell-side advisor.
Talk to the deal team
Kim Harpøth Jespersen
Senior AssociateCopenhagen, Denmark
VHZ Group has been acquired by Gilde Equity Management and VHZ Group’s management
VHZ Group, the market leader in the Dutch B2B uPVC windows and doors market, has been acquired by Gilde Equity Management (GEM) together with the company’s management. With the acquisition, VHZ Group and GEM will be able to further expand on the company’s strategy and vision.Learn more
ScreenPoint Medical has raised US$28 million in a Series C investment round led by Insight Partners
Netherlands-based ScreenPoint Medical, an AI technology company that develops advanced image recognition and machine learning software to improve early detection of breast cancer, has raised US$28 million (€24 million) in a Series C funding round led by New York-based global venture capital and private equity firm Insight Partners to further develop its technology and accelerate commercial growth of the company’s Transpara AI breast care software.Learn more
esignatur has been acquired by Scrive
esignatur has been acquired by Scrive, a portfolio company of Vitruvian Partners. esignatur and Scrive both specialize in digital signing solutions and complement each other with strong geographical and sector reach.Learn more